CV Therapeutics
1990
FOUNDED
M&A
STATUS
801-900
EMPLOYEES
M&A
LATEST DEAL TYPE
$1.4B
LATEST DEAL AMOUNT
1
INVESTORS
Description
Developer and marketer of novel, small molecule drugs for the treatment of cardiovascular diseases. The company's major products were Ranexa (ranolazine extended-release tablets) and Lexiscan (regadenoson).
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Office
- 3172 Porter Dr
- Palo Alto, CA 94304
- United States
+1 (650) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore CV Therapeutics’s full profile, request a free trial.
CV Therapeutics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 17-Apr-2009 | $1.4B | 00000 | 00.00 | Completed | Generating Revenue |
| 8. PIPE | 16-Apr-2008 | 00000 | 00000 | Completed | Generating Revenue | |
| 7. PIPE | 18-Apr-2006 | 00000 | 00000 | Completed | Generating Revenue | |
| 6. PIPE | 01-Aug-2000 | 00000 | 00000 | Completed | Generating Revenue | |
| 5. IPO | 06-Oct-1999 | 0000 | 00000 | Completed | Generating Revenue | |
| 4. Later Stage VC (Series G) | 01-May-1996 | 000.00 | 000.00 | Completed | Generating Revenue | |
| 3. Later Stage VC (Series E) | 01-Nov-1995 | 00.000 | 000.00 | Completed | Generating Revenue | |
| 2. Later Stage VC (Series D) | 01-Apr-1994 | $16.5M | $23.4M | Completed | Generating Revenue | |
| 1. Later Stage VC (Series C) | 01-Jul-1993 | $6.88M | $6.88M | Completed | Generating Revenue |
CV Therapeutics Former Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Acqua Wellington | PE/Buyout | Minority | 000 0000 | 000000 0 | ||
| Alloy Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Asset Management Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Banexi Ventures Partners | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| CHL Medical Partners | Venture Capital | Minority | 000 0000 | 000000 0 |